PaceyCuff Association with Peapod Mats

Pacey Medtech meets with Peapod Mats 

Outstanding Vancouver company and veterans of Dragon's Den Canada meets with Pacey Medteech to share great war stories and not a few moments of humour.  Peapod Mats great online  service and great contribution to the field of continence is well known in North America and elsewhere. There is a natural interest in learning and sharing ways of helping people with incontinence. The Peapod Mat is super technology as is the PaceyCuff.

Brachytherapy urinary incontinence and PaceyCuff

Send to

Brachytherapy induced uroincontinence is a well known but infrequent (4.4%) result of therapy.
Whereas the post surgical result , often including radiation Rx may be 11-12% .
PaceyCuff urethral control device may be used in both forms of the complication.
paceycuff.com

Urology. 2016 Sep;95:151-7. doi: 10.1016/j.urology.2016.05.021. Epub 2016 May 19.

paceycuff.com

Urinary Incontinence Following Prostate Brachytherapy.

Leapman MS1, Stone NN2, Mock S3, Stock RG2, Hall SJ4.

OBJECTIVE:

To define the incidence, time course, and risk factors associated with the
development of urinary incontinence (UI) following prostate brachytherapy.

MATERIALS AND METHODS:

A total of 2461 men were identified who underwent permanent
 interstitial prostate brachytherapy with or without external
beam radiation therapy. We examined the relationship between clinical- and treatment-related
 variables with the onset of UI, defined as leakage requiring pad usage, and further classified
 as stress (SUI) or urge (UUI) predominant, using univariate and Cox proportional hazards
regression models. The changes in International Prostate Symptom Score and quality of life
domains were assessed from baseline to last follow, and examined by UI status.

RESULTS:

Patients were followed for a median of 6.4 years (interquartile range 4.1-9.3).
UI was reported in 108 individuals (4.4%), at a median of 1.8 years
(interquartile range 5 months-4.4 years): 30 with SUI and 78 with UUI. Seventy-two men (66.7%)
 reported using 1, 24 (22.2%) using 2, and 12 (11%) using ≥3 pads per day. On multivariate
analysis, post-implantation transurethral resection of the prostate, urinary retention, 
external beam radiation therapy, and higher pretreatment International Prostate 
Symptom Score were significantly associated with the development of SUI, 
although transurethral resection of the prostate was the only significant risk factor 
associated with SUI. Men experiencing UI reported greater declines in urinary 
quality of life; however, no significant difference was observed between SUI and UUI.

CONCLUSION:

UI occurred in 4.4% of patients following prostate brachytherapy
and is more commonly urge-predominant in character. Distinct risk factors
exist for the development of UUI vs SUI. Urinary leakage requiring pad usage was associated
with declines in urinary QOL.